Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
Are you curious about new technologies, and how they can lead to long-term sustainable value?
We think creatively at the intersection of business and technology, inventing solutions to redefine what you do.
You need a partner with intimate knowledge of your industry and proven experience of delivering value from deep tech breakthroughs.
Discover more about the work we do in your sector and how we can create real commercial advantage for you.
Take a look at the latest insights, ideas and perspectives from CC.
Explore a cross-section of up-to-date content on the deep tech trends shaping the future of business and society.
Are you looking for an opportunity for your abilities to be recognised, and make a real difference?
Whether you are just starting out or you’re an experienced professional, we would love to hear from you.
by Dave Gladwin | 1st June 2022 | Life sciences, Newsroom, Pharmaceuticals, Uncategorized
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
by Dave Gladwin and Madeline Cheah | 10th March 2022 | Defence and Security, Newsroom, Smart infrastructure, Uncategorized
A holistic approach is essential to making sure that the security of machines involved in a large-scale autonomous project can be trusted.